A breakthrough in the quest to find a blood test for Alzheimer's will help doctors and patients "manage the disease", one of the researchers has said.
Professor Howard Federoff explained:
Our novel blood test offers the potential to identify people at risk for progressive cognitive decline and can change how patients, their families and treating physicians plan for and manage the disorder.
The preclinical state of the disease offers a window of opportunity for timely disease-modifying intervention.
Biomarkers such as ours that define this asymptomatic period are critical for successful development and application of these therapeutics.
We consider our results a major step toward the commercialisation of a preclinical disease biomarker test.
More top news
A 43rd generation direct descendant of the Prophet Muhammad, the Prince has vowed to clean up Fifa's act.
So-called legal highs are set to be banned en masse. But what are they, and why is this drastic move necessary?
The Swiss 79-year-old joined Fifa in 1975, with his reign as president starting in 1998. But who is he?